Ensayos clínicos

Inclusion Criteria: 

• Patients 18 to 100 years of age
• Patients who are scheduled for a clinically indicated F-18 FDG PET/CT study
• Patients who are able and willing to sign the informed consent will be enrolled
• Patients at high risk for multiple sites of F-18 FDG avid abnormalities based on prior clinical or radiologic evaluation or those who demonstrate multiple sites of abnormal FDG uptake on their clinical PET/CT scan will be selected for participation.In this way patients will be enrolled who provide the highest likelihood of having multiple FDG avid sites to serve as evaluable comparisons between the standard PET/CT scan and the PET/MR scan.
• Patients who have a BMI of at least 18.5 kg/m2
• Patients who pass standard clinical MRI screening procedures

Eligibility Criteria:

• Patients who are unable to lay quietly for an additional 60 minutes of imaging
• Patients who are claustrophobic
• Patients who weigh more than 350 lbs or whose body habitus precludes them from participation